Journal List > J Korean Soc Spine Surg > v.22(4) > 1076064

Kim, Park, and Rhyu: Variations in Matrix Metalloproteinase Expression by Disc Location in Patients with Sequestrated Lumbar Disc Herniation

Abstract

Study Design

In vivo study

Objectives

To evaluate variations in matrix metalloproteinase (MMP) expression levels according to the disc location in patients with sequestrated lumbar disc herniation.

Summary of Literature Review

MMPs are considered to be the major catabolic enzymes in the intervertebral disc. MMPs have been known to be the primary mediators of extracellular matrix (ECM) degradation, to play major roles in disc degeneration by changing the collagens and the extracellular matrix, and to be involved in the processes of apoptosis and autoresorption of herniated disc materials by inducing inflammatory cytokines.

Materials and Methods

The sequestered and contained disc materials were removed from seven patients with sequestered lumbar disc herniations. The materials from the contained discs were classified into group 1 and those of the sequestered discs into group 2. Immunochemistry tests were conducted for the tissues of both groups. The expression levels of MMP-1, 3, and 13 were checked using a fluorescence microscope. The amount of expression of each MMP was calculated using the percentage of expressed cells and analyzed statistically.

Results

In the histological study, increased expression of MMP-1, 3, and 13 was found in group 2. In the statistical analysis after the quantification of MMP expression, the expression of all MMPs was found to have increased significantly in group 2 (p<0.05).

Conclusions

The increased expression of MMP-1, 3, and 13 indicated that the inflammation and degeneration processes, and the spontaneous resorption by the surrounding tissues were more active in the sequestered disc group than in the contained disc group.

REFERENCES

1. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003; 92:827–39.
2. Cawston T, Carrere S, Catterall J, et al. Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. No-vartis Found Symp. 2001; 234:205–18.
crossref
3. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69:562–73.
crossref
4. Fillmore HL, VanMeter TE, Broaddus WC. Membrane-type matrix metalloproteinases (MTMMPs): expression and function during glioma invasion. J Neurooncol. 2001; 53:187–202.
5. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol. 2001; 13:534–40.
6. Vo NV, Hartman RA, Yurube T, et al. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J. 2013; 13:331–41.
7. Weiler C, Nerlich AG, Zipperer J, et al. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J. 2002; 11:308–20.
crossref
8. Gruber HE, Ingram JA, Hanley EN Jr. Immunolocalization of MMP-19 in the human intervertebral disc: implications for disc aging and degeneration. Biotech Histochem. 2005; 80:157–62.
crossref
9. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004; 204:47–54.
crossref
10. Richardson SM, Doyle P, Minogue BM, et al. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther. 2009; 11:R126.
crossref
11. Roberts S, Caterson B, Menage J, et al. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976). 2000; 25:3005–13.
12. Bachmeier BE, Nerlich A, Mittermaier N, et al. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J. 2009; 18:1573–86.
crossref
13. Crean JK, Roberts S, Jaffray DC, et al. Matrix metalloproteinases in the human intervertebral disc: role in disc degeneration and scoliosis. Spine (Phila Pa 1976). 1997; 22:2877–84.
crossref
14. Le Maitre CL, Freemont AJ, Hoyland JA. Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem. 2006; 81:125–31.
crossref
15. Tsarouhas A, Soufla G, Katonis P, et al. Transcript levels of major MMPs and ADAMTS-4 in relation to the clinico-pathological profile of patients with lumbar disc herniation. Eur Spine J. 2011; 20:781–90.
crossref
16. Genevay S, Finckh A, Mezin F, et al. Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Res Ther. 2009; 11:R169.
crossref
17. Haro H, Komori H, Kato T, et al. Experimental studies on the effects of recombinant human matrix metalloproteinases on herniated disc tissues–how to facilitate the natural resorption process of herniated discs. J Orthop Res. 2005; 23:412–9.
crossref
18. Kato T, Haro H, Komori H, et al. Sequential dynamics of inflammatory cytokine, angiogenesis inducing factor and matrix degrading enzymes during spontaneous resorption of the herniated disc. J Orthop Res. 2004; 22:895–900.
crossref

Figures and Tables%

Fig. 1.
Results of immunohistochemistry for specimens (100×). The bright areas indicate the increased fluorescence intensity for the expression of each MMP. The expression of MMP-1 (A), -3 (B), and -13 (C) in group 1 was observed. In group 2, the expression of MMP-1 (D), MMP-3 (E), and MMP-13 (F) was increased much more than that of group 1.
jkss-22-160f1.tif
Fig. 2.
Variation in MMP expression in each group. Positive pixels indicate increased fluorescence intensity of more than 50%. The quantified expression of MMPs was calculated using the percentage of positive pixels with respect to the reference pixels.
jkss-22-160f2.tif
Table 1.
The Qualified Expressions of MMPs were Calculated by the Percentages of Positive Pixels to the Reference Pixels
Group 1 Group 2 P-values
No. of positive pixels % of positive pixels No. of positive pixels % of positive pixels Paired t-test
MMP-1 118,934±30,951 29.11±7.98 209,502±76,289 51.28±18.67 0.002
MMP-3 54,174±18,761 13.26±4.59 103,834±28,686 25.41±7.02 0.020
MMP-13 29,994±11,575 7.34±2.83 83,231±35,184 20.37±8.61 0.006
TOOLS
Similar articles